drugset / Trial / NCT02284919
[18F]ISO-1 Positron Emission Tomography (PET/CT) in Primary Breast Cancer
NaSingle-groupOpen-labelDiagnostic
Summary
In this study, positron emission tomography (PET/CT) imaging will be used to evaluate sigma-2 (σ2) receptor activity in sites of primary breast cancer using the investigational radiotracer \[18F\]ISO-1.
Timeline
- Start
- 2015-03-11
- Primary completion
- 2026-11
- Completion
- 2026-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 18F-ISO-1 | Diagnostic / imaging agent | 278 mbq | Other |
| Subject | 18F-ISO-1 | Diagnostic / imaging agent | 527 mbq | Other |